Surprisingly, I find this study to be credible.
To understand why, let's start with some background:
Following prostate removal, or radiation treatment for prostate cancer, many men experience severe ED due to damage to nerves and blood vessels. Some men recover the ability to have an erection over time, as tissues heal.
However, because the men are not having regular erections, there isn't enough blood flow into the penis to maintain healthy tissues. For this reason, many urologists will prescribe a daily dose of Cialis (tadalafil) to maintain the health of the penis, and promote healing.
This is an "off label" use of Cialis. The urologists are prescribing it for something other than its intended and approved purpose. And the manufacturers cannot claim that it is effective for this purpose, because the FDA has not approved it.
So, the idea that Cialis might encourage healing and regeneration of erectile tissues by maintaining healthy blood flow is well known, despite lack of FDA approvals, or manufacturer claims.
Of course, it would be premature to jump to conclusions based on a single study; it's important to understand how clinical studies work, and especially how they relate to FDA approval for specific uses (in the United States).
Citations
Erectile preservation following radical prostatectomy
Tadalafil therapy for erectile dysfunction following prostatectomy